Details of the Drug
General Information of Drug (ID: DMGD0HT)
| Drug Name |
Tellurium
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Tellurium; 13494-80-9; Telloy; Tellur; Aurum paradoxum; Tellurium element; Tellur [Polish]; Metallum problematum; Tellurium, metallic; Tellurium, elemental; Tellurium Atom; UNII-NQA0O090ZJ; Tellurium and compounds; HSDB 2532; NCI-C60117; EINECS 236-813-4; NQA0O090ZJ; teluro; Tellurium, 99+%, (trace metal basis), powder; Tellurium, 99.999%, (trace metal basis), powder; tellure; Tellurium compounds, n.o.s.; Tellurium, 99.8%, (trace metal basis), powder, -200 mesh; Tellurium powder; Tellurium compounds; ACMC-1BQVR; 52Te; EC 236-813-4
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 |
Molecular Weight | 127.6 | |||||||||||||||||
| Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||
| Rotatable Bond Count | 0 | ||||||||||||||||||
| Hydrogen Bond Donor Count | 0 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count | 0 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


